Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
about
Mammary Development and Breast Cancer: A Wnt PerspectiveThe detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaCircadian disruption and breast cancer: an epigenetic link?Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature reviewWnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesisCoexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma.Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cellsAberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancerKey signaling nodes in mammary gland development and cancer: β-catenin.Upregulated microRNA-92b regulates the differentiation and proliferation of EpCAM-positive fetal liver cells by targeting C/EBPß.Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitroThe GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brainAssessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumourDietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation.DNA methylation status of REIC/Dkk-3 gene in human malignanciesAbsence of Dickkopf (Dkk)-3 protein expression is correlated with longer disease-free survival and lower incidence of metastasis in head and neck squamous cell carcinoma.The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer.Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer.Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signallingThe integrative epigenomic-transcriptomic landscape of ER positive breast cancer.Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritisAberrant promoter CpG methylation and its translational applications in breast cancer.GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.Regulation of breast cancer stem cell features.Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.The roles of REIC gene and its encoding product in gastric carcinoma.TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy.Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5.A Cytokine-Like Protein Dickkopf-Related Protein 3 Is Atheroprotective.p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.DNA Methylation and the HOXC6 Paradox in Prostate Cancer.Dickkopf-3 function in the prostate: implications for epithelial homeostasis and tumor progression.Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells.
P2860
Q26740086-035D5825-A196-4C85-B9A1-9BA2CF3ED846Q26750641-66193005-2502-49CC-9E0F-B56FA5928DA5Q26798258-23D3E4C0-D5E4-4EDD-9E85-1B9F74329DBBQ28086989-89019A97-474E-4BB7-B2F3-9F8EC46E5855Q33685717-26EC64FE-7D98-4A12-A7C7-3211D0512460Q33739319-6B79E1E1-98D8-4D57-96DA-B5FFC27AE4A7Q33739448-82D9EC30-F349-4F81-A475-4D2697C2B5CDQ34154767-77738390-E4C0-49F5-A27C-C1ECC739427CQ34449043-DCEF80B8-24EB-484D-9551-B5FF3A441F56Q34613461-A4141098-E1AA-415E-9D90-04E2B5858CE1Q34924005-45DB012A-4D27-4FD3-862C-A00F2CA2CFA3Q35117267-53652BAA-4F6A-4CEF-9EF4-701EF83DAAF1Q35235941-4DB693EC-21A6-4735-8ED1-6CE8020F96A1Q35687321-8F7D7A45-DAAC-40C5-A350-C5BCF4668DF7Q35801963-D9298FD1-DF76-485C-8104-03FBE567B8E7Q35833171-34DE43C5-8BA3-49B6-9E24-5ABC7E96E859Q35886349-950B8ADF-8DE6-4802-B1A6-DD095441DD66Q35995423-35D84506-0447-4CAA-BE79-DD96F7EE7F5AQ36005081-0D07B50B-6207-4FD7-BF94-1295FD86F006Q36088521-5139808C-07B5-4FE8-AF71-0FC7F9CD321FQ36341597-620DA154-F497-4D90-BB56-6CF3DEA77611Q36357800-F9246A11-3C84-49E6-9549-372557AC558EQ37269453-BF0DD184-EDBE-4620-B54C-1E26CF0F90CBQ37354053-51E311F8-E310-4536-91C5-33C3775F7D42Q37718457-0EC8DE6D-0FDC-4DAA-958A-436AF557B501Q38210247-980AA684-1806-448E-8796-AB78F62204EBQ38359738-7DA6BB4E-0CD7-48D1-9C71-D64418F22861Q38438819-E32609F9-1C89-43D6-9163-9AFCB73254D8Q39154095-E78A8F80-2977-46EA-B666-3B876DA3B30BQ39220891-C5BFD4FC-2EF7-46E5-8E80-6E1CE483C019Q39379134-4BE598B2-416F-43D3-9C57-F18B7B1FA248Q39434911-47358011-EA83-4F59-9357-0001DEBBCA78Q39533563-2AC11F3D-5908-4535-9EEB-FB9795DFD630Q39542401-452D185C-321D-4A1D-9B6C-FCE8811FB1D6Q41183905-74E67AD0-3167-4015-9311-495745F9F4D4Q42073870-E070C962-61AC-40BB-9FBE-C14A7B035D18Q42362115-4EF35548-8B13-4B1E-8FE3-CB779711CC9CQ42585509-896D56DD-8B18-454D-A1E3-45F596066C9CQ43086153-C4A95781-E415-4FCB-BEBA-90F3A65C5DA5Q43117791-119D1C3F-2872-4AE2-8CBE-1810CE47C64D
P2860
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@ast
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@en
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@en-gb
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@nl
type
label
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@ast
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@en
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@en-gb
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@nl
prefLabel
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@ast
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@en
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@en-gb
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@nl
P2860
P50
P3181
P356
P1433
P1476
Prognostic relevance of Wnt-in ...... ylation in human breast cancer
@en
P2093
Arndt Hartmann
Peter J Wild
P2860
P2888
P3181
P356
10.1186/1471-2407-9-217
P407
P577
2009-01-01T00:00:00Z
P5875
P6179
1029428256